aTyr Pharma (ATYR)
NASDAQ:ATYR
Holding ATYR?
Track your performance easily

aTyr Pharma (ATYR) Financial Statements

1,835 Followers

aTyr Pharma Financial Overview

aTyr Pharma's market cap is currently ―. The company's EPS TTM is $-0.905; its P/E ratio is -2.01; aTyr Pharma is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-$ 235.00K-$ 353.00K-
Gross Profit-$ 235.00K-$ 353.00K-
EBIT$ -16.31M$ -16.64M$ -15.96M$ -12.62M$ -12.34M
EBITDA$ -15.11M$ -15.87M$ -15.55M$ -11.62M$ -12.64M
Net Income Common Stockholders$ -16.31M$ -15.49M$ -14.76M$ -11.34M$ -12.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 78.48M$ 84.50M$ 98.17M$ 102.13M$ 108.58M
Total Assets$ 105.94M$ 113.24M$ 120.67M$ 125.07M$ 132.73M
Total Debt$ 13.85M$ 14.13M$ 15.10M$ 15.22M$ 15.39M
Net Debt$ -64.63M$ -70.37M$ -83.07M$ -86.91M$ -93.19M
Total Liabilities$ 24.52M$ 28.97M$ 30.18M$ 26.87M$ 26.70M
Stockholders Equity$ 81.61M$ 84.48M$ 90.68M$ 98.39M$ 106.26M
Cash Flow-
Free Cash Flow$ -20.46M$ -22.40M$ -11.08M$ -10.12M$ -14.39M
Operating Cash Flow$ -20.45M$ -22.38M$ -11.06M$ -9.56M$ -12.01M
Investing Cash Flow$ 6.73M$ -1.36M$ 17.82M$ 4.38M$ -4.16M
Financing Cash Flow$ 13.40M$ 7.73M$ 6.03M$ 2.68M$ 8.02M
Currency in USD

aTyr Pharma Earnings and Revenue History

aTyr Pharma Debt to Assets

aTyr Pharma Cash Flow

aTyr Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis